"disialoganglioside" meaning in All languages combined

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "di-",
        "3": "sialoganglioside"
      },
      "expansion": "di- + sialoganglioside",
      "name": "af"
    }
  ],
  "etymology_text": "From di- + sialoganglioside.",
  "forms": [
    {
      "form": "disialogangliosides",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "disialoganglioside (plural disialogangliosides)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms prefixed with di-",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with 1 entry",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "Pages with entries",
          "parents": [],
          "source": "w"
        }
      ],
      "examples": [
        {
          "ref": "2015 July 27, Wei Wang et al., “NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy”, in Frontiers in Immunology, volume 6, →DOI:",
          "text": "GD2 is a disialoganglioside expressed on human melanoma and neuroblastoma cells with restricted expression on normal tissues, which makes it a suitable target for mAb immunotherapy (Table 1 ).",
          "type": "quote"
        }
      ],
      "glosses": [
        "A ganglioside that has two sialic acid residues"
      ],
      "id": "en-disialoganglioside-en-noun-xAQ-g8rK",
      "links": [
        [
          "ganglioside",
          "ganglioside"
        ],
        [
          "sialic acid",
          "sialic acid"
        ]
      ]
    }
  ],
  "word": "disialoganglioside"
}

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "di-",
        "3": "sialoganglioside"
      },
      "expansion": "di- + sialoganglioside",
      "name": "af"
    }
  ],
  "etymology_text": "From di- + sialoganglioside.",
  "forms": [
    {
      "form": "disialogangliosides",
      "tags": [
        "plural"
      ]
    }
  ],
  "head_templates": [
    {
      "args": {},
      "expansion": "disialoganglioside (plural disialogangliosides)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English countable nouns",
        "English entries with incorrect language header",
        "English lemmas",
        "English nouns",
        "English terms prefixed with di-",
        "English terms with quotations",
        "Pages with 1 entry",
        "Pages with entries"
      ],
      "examples": [
        {
          "ref": "2015 July 27, Wei Wang et al., “NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy”, in Frontiers in Immunology, volume 6, →DOI:",
          "text": "GD2 is a disialoganglioside expressed on human melanoma and neuroblastoma cells with restricted expression on normal tissues, which makes it a suitable target for mAb immunotherapy (Table 1 ).",
          "type": "quote"
        }
      ],
      "glosses": [
        "A ganglioside that has two sialic acid residues"
      ],
      "links": [
        [
          "ganglioside",
          "ganglioside"
        ],
        [
          "sialic acid",
          "sialic acid"
        ]
      ]
    }
  ],
  "word": "disialoganglioside"
}